Search

everythinglearnresearchcommunity

for

Search:↓

The Brazilian version of the Alopecia Areata Quality of Life Index is reliable for assessing patients' quality of life.

Alopecia areata affects life quality differently based on its severity.

Alopecia areata affects quality of life more in adolescents than adults.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

The Polish version of the Alopecia Areata Quality of Life Index is a reliable tool for assessing quality of life in Polish-speaking patients with alopecia areata.

Children with alopecia areata and their caregivers experience significant emotional and quality of life challenges.

Unmarried individuals and those with diabetes have a poorer quality of life with alopecia areata.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Hair loss significantly affects emotional and social well-being.

Hair loss significantly affects emotional and social well-being.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

Alopecia negatively affects quality of life and mental health.

The AAcQLI is a promising tool for assessing quality of life in children with alopecia areata.

Alopecia areata treatment should consider life quality and mental health, not just clinical results.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Alopecia Areata significantly reduces quality of life, especially in women, long-term sufferers, and severe cases.

The new tool helps measure the impact of alopecia areata on children's quality of life.

Alopecia areata greatly affects quality of life, needing psychological support.

Hair loss significantly affects quality of life and mental health, causing anxiety and depression.

Hair loss from alopecia areata and androgenetic alopecia moderately affects the quality of life, especially in younger patients and those with long-term hair loss, impacting both their physical and emotional well-being.

Nepalese patients with hair loss, especially women and those with androgenetic alopecia, experience a significant decrease in quality of life.

Siddha therapeutics successfully treated a 14-year-old's alopecia areata, leading to full hair regrowth without side effects.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Scalp hair loss significantly worsens life quality for many children, especially as they age.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Minoxidil with triamcinolone acetonide is more effective for mild alopecia areata when injected with microneedles than when applied topically.

Alopecia areata progression is linked to stress and hormone changes, suggesting new treatment targets.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Photobiomodulation therapy effectively promotes hair regrowth and improves quality of life in alopecia areata without side effects.